Eli Lilly and its rivals, including Denmark's Novo Nordisk, are in a race to dominate the booming market for obesity and diabetes drugs.
from mint - science https://ift.tt/d60Hp1j
Sunday, 7 June 2026
A weight-loss drug that also controls sleep apnea and knee pain: Eli Lilly may have found one
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment